http://home.comcast.net/~creationsunltd/insulinresistance.htm

Healthy Eating Choices

http://home.comcast.net/~cnmpat/healthyplans.htm

 

Gestational Diabetes

Gestational Diabetes Overview

What is it ?

Diabetes that develops during the pregnancy.
Gestational diabetes mellitus (GDM) is defined as any degree of glucose intolerance with onset or first recognition during pregnancy
GDM will disappears post birth, but increases the risk that the mother will develop diabetes later. Usually GDM is managed with meal planning, activity, and, in some cases, insulin.
The goal of management is to keep the blood sugar within a normal range, to decrease the risks of complications for the mom and the baby. Pregnancy becomes a good time to pay attention to diet and exercise, and establish good health habits.
It is thought pregnancy is an insulin resistance condition, and in some individuals, the ability to control blood sugar becomes more difficult.
Approximately 7% of all pregnancies are complicated by GDM, resulting in more than 200,000 cases annually. The prevalence may range from 1 to 14% of all pregnancies, depending on the population studied and the diagnostic tests employed.

Diagnosis

Glucose Challenge Test
Follow-up Glucose Challenge Test
Two-step approach:
Perform an initial screening by measuring the plasma or serum glucose concentration 1 h after a 50-g oral glucose load (glucose challenge test [GCT]) and perform a diagnostic OGTT on that subset of women exceeding the glucose threshold value on the GCT. When the two-step approach is employed, a glucose threshold value >140 mg/dl (7.8 mmol/l) identifies approximately 80% of women with GDM, and the yield is further increased to 90% by using a cutoff of >130 mg/dl (7.2 mmol/l).
 

Healthy Eating and Lifestyle Changes

Handouts

Current Nutritional Guidelines for Gestational Diabetes

Restriction of carbohydrates to 35–40% of calories has been shown to decrease maternal glucose levels and improve maternal and fetal outcomes.

Post Birth Follow-up

Reclassification of maternal glycemic status should be performed at least 6 weeks after birth.
If glucose levels are normal post-partum, reassessment of glycemia should be undertaken at a minimum of 3-year intervals. Women with IFG or IGT in the postpartum period should be tested for diabetes annually; these patients should receive intensive nutrition guidance, and  should be placed on an individualized exercise program because of their very high risk for development of diabetes.
All patients with prior GDM should be educated regarding lifestyle modifications that lessen insulin resistance, including maintenance of normal body weight through MNT and physical activity. Medications that worsen insulin resistance (e.g., glucocorticoids, nicotinic acid) should be avoided if possible. Patients should be advised to seek medical attention if they develop symptoms suggestive of hyperglycemia.
Education should also include the need for family planning to ensure optimal glycemic regulation from the start of any subsequent pregnancy. Low-dose estrogen-progestogen oral contraceptives may be used in women with prior histories of GDM, as long as no medical contraindications exist.
 
Gestational Diabetes MellitusPDF Logo
http://care.diabetesjournals.org/cgi/reprint/26/suppl_1/s103
 
Criteria for the diagnosis of diabetes mellitus
Normoglycemia IFG and IGT Diabetes mellitus*

FPG <110 mg/dl FPG >=110 mg/dl and <126 mg/dl (IFG) FPG >=126 mg/dl
2-h PG{dagger} <140 mg/dl 2-h PG{dagger} >=140 mg/dl and <200 mg/dl (IGT) 2-h PG{dagger} >=200 mg/dl
Symptoms of DM and casual plasma glucose concentration >=200 mg/dl

Pat Sonnenstuhl, RN, CNM, Nutrition Support

Contact Information: cnmpat@comcast.net

Creations Unlimited
http://home.comcast.net/~creationsunltd/
Healthy Lifestyle Choices
http://home.comcast.net/~cnmpat/siteindex.htm
Professional Book and Web Site Promotion
http://home.comcast.net/~cnmpat/bookrevtoc.htm

Disclaimer: The focus of this site is non-pharmaceutical management, but rather the basics of prevention. Please check with your health care provider about specific pharmaceutical management.

If you suspect you have IR or one if its associated conditions, please seek accurate diagnosis and research thoroughly all aspects of the conditions. I recommend working carefully with your health care provider, to learn what is the most appropriate management for you.

Updated 5-2-2008